Resultados de búsqueda - Seferovic, P
-
1
The 'Peptide for Life' Initiative: a call for action to provide equal access to the use of natriuretic peptides in the diagnosis of acute heart failure across Europe.
Artículo | por Bayes-Genis, A; Januzzi, JL; Richards, AM; Arfsten, H; de Boer, RA; Emdin, M; Gonzalez, A; Jaarsma, T; Jhund, PS; Mueller, C; Nunez, J; Rossignol, P; Milinkovic, I; Rosano, GMC; Coats, A; Seferovic, P | Publicado 2021 | -
2
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Artículo | por Ryden, L; Grant, PJ; Anker, SD; Berne, C; Cosentino, F; Danchin, N; Deaton, C; Escaned, J; Hammes, HP; Huikuri, H; Marre, M; Marx, N; Mellbin, L; Ostergren, J; Patrono, C; Seferovic, P; Uva, MS; Taskinen, MR; Tendera, M; Tuomilehto, J; Valensi, P; Zamorano, JL; Badimón L.; ESC; EASD | Publicado 2013 | -
3
Implementation of guideline-recommended medical therapy for patients with heart failure in Europe
Artículo | por Volterrani, M.; Seferovic, P.; Savarese, G.; Spoletini, I.; Imbalzano, E.; Bayés-Genís, Antoni|||0000-0002-3044-197X; Jankowska, E.; Senni, M.; Metra, M.; Chioncel, O.|||0000-0002-3197-3628; Coats, A.J.S.; Rosano, G.M.C. | Publicado 2025 | -
4
ESC Guidelines on diabetes, pre- diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary
Artículo | por Ryden, L; Grant, PJ; Anker, SD; Berne, C; Cosentino, F; Danchin, N; Escaned, J; Hammes, HP; Huikuri, H; Marre, M; Marx, N; Mellbin, L; Ostergren, J; Patrono, C; Seferovic, P; Sousa, M; Taskinen, MR; Tuomilehto, J; Valensi, P; Zamorano, JL; Achenbach, S; Bax, JJ; Bueno, H; Dean, V; Deaton, C; Erol, C; Ferrari, R; Kirchhof, P; Lancellotti, P; Linhart, A; Nihoyannopoulos, P; Piepoli, MF; Tendera, M; Torbicki, A; Wijns, W; Windecker, S; De Backer, G; Sirnes, PA; Ezquerra, EA; Avogaro, A; Badimon, L; Baranova, E; Baumgartner, H; Betteridge, J; Ceriello, A; Fagard, R; Funck-Brentano, C; Gulba, DC; Hasdai, D; Hoes, AW; Kjekshus, JK; Knuuti, J; Kolh, P; Lev, E; Mueller, C; Neyses, L; Nilsson, PM; Perk, J; Ponikowski, P; Reiner, Z; Sattar, N; Schachinger, V; Scheen, A; Schirmer, H; Stromberg, A; Sudzhaeva, S; Tamargo, JL; Viigimaa, M; Vlachopoulos, C; Xuereb, RG | Publicado 2014 | -
5
Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the European Society of Cardiology
Artículo | por Gustafsson, F.; Damman, K.; Nalbantgil, S.; Van Laake, L.W.; Tops, L.F.; Thum, T.; Adamopoulos, S.; Bonios, M.; Coats, A.J.S.; Crespo Leiro, Marisa; Mehra, M.R.; Filippatos, G.; Hill, L.; Metra, M.; Jankowska, E.; de Jonge, N.; Kaye, D.; Masetti, M.; Parissis, J.; Milicic, D.; Seferovic, P.; Rosano, G.; Ben Gal, T. | Publicado 2023 | -
6
Participation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP Heart F...
Artículo | por Kapelios, C.J.; Benson, L.; Crespo Leiro, Marisa; Anker, S.D.; Coats, A.J.S.; Chioncel, O.; Filippatos, G.; Lainscak, M.; McDonagh, T.; Mebazaa, A.; Metra, M.; Piepoli, M.F.; Rosano, G.M.C.; Ruschitzka, F.; Savarese, G.; Seferovic, P.M.; Volterrani, M.; Maggioni, A.P.; Lund, L.H. | Publicado 2023 | -
7
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology.
Artículo | por Nunez, J; de la Espriella, R; Rossignol, P; Voors, AA; Mullens, W; Metra, M; Chioncel, O; Januzzi, JL; Mueller, C; Richards, AM; De Boer, RA; Thum, T; Arfsten, H; Gonzalez, A; Abdelhamid, M; Adamopoulos, S; Anker, SD; Gal, TB; Biegus, J; Cohen-Solal, A; Bohm, M; Emdin, M; Jankowska, EA; Gustafsson, F; Hill, L; Jaarsma, T; Jhund, PS; Lopatin, Y; Lund, LH; Milicic, D; Moura, B; Piepoli, MF; Ponikowski, P; Rakisheva, A; Ristic, A; Savarese, G; Tocchetti, CG; Van Linthout, S; Volterrani, M; Seferovic, P; Rosano, G; Coats, AJS; Bayes-Genis, A | Publicado 2022 | -
8
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Fail...
Artículo | por Maggioni, AP; Anker, SD; Dahlstrom, U; Filippatos, G; Ponikowski, P; Zannad, F; Amir, O; Chioncel, O; Leiro, MC; Drozdz, J; Erglis, A; Fazlibegovic, E; Fonseca, C; Fruhwald, F; Gatzov, P; Goncalvesova, E; Hassanein, M; Hradec, J; Kavoliuniene, A; Lainscak, M; Logeart, D; Merkely, B; Metra, M; Persson, H; Seferovic, P; Temizhan, A; Tousoulis, D; Tavazzi, L; Roig E.; Mirabet S.; ESC HFA | Publicado 2013 | -
9
Long-term safety of intravenous cardiovascular agents in acute heart failure: results from the European Society of Cardiology Heart Failure Long-Term Registry
Artículo | por Mebazaa, A; Motiejunaite, J; Gayat, E; Crespo-Leiro, MG; Lund, LH; Maggioni, AP; Chioncel, O; Akiyama, E; Harjola, VP; Seferovic, P; Laroche, C; Julve, MS; Roig, E; Ruschitzka, F; Filippatos, G; ESC Heart Failure Long-Term Regist | Publicado 2018 | -
10
The ‘Peptide for Life’ Initiative: a call for action to provide equal access to the use of natriuretic peptides in the diagnosis of acute heart failure across Europe
Artículo | por Bayes-Genis, A. (Antoni)|||/items/896bbeec-9322-439b-a042-fd865eaa7f6f; Januzzi, J.L. (James L.)|||/items/415c6d1d-4777-4ce2-83f5-f47b83624d87; Richards, A.M. (A. Mark)|||/items/00c44847-ac1c-4b0d-b4b0-77b99bc22591; Arfsten, H. (Henrike)|||/items/894e190e-3b73-46f9-99ba-646515e36c25; Boer, R.A. (Rudolf A.) de|||/items/9f1f2d4d-6bf8-42bb-8e4c-4a16e0d99249; Emdin, M. (Michele)|||/items/011b9548-6a29-4564-a97b-4f87ba86ce72; Gonzalez, A. (Arantxa)|||/items/9c64c0f4-66b4-4b51-8593-0e50c091a515; Jaarsma, T. (Tiny)|||/items/331c6b9d-0ef6-445d-9f07-4d71dbccaa25; Jhund, P.S. (Pardeep S.)|||/items/73c63a25-f21f-4131-bc01-745156717c2c; Mueller, C. (Christian)|||/items/c67c5144-ae39-45df-ad65-3d6bab0d80a8; Núñez, J. (Julio)|||/items/b111a25e-e309-4405-aab3-5f4bb4677530; Rossignol, P.(Patrick)|||/items/b3bcdda1-3e77-431e-9d1b-fea2d3ab17d4; Milinkovic, I. (Ivan)|||/items/fc6d5366-b640-4487-a6aa-13dfcd4cc042; Rosano, G. (Giuseppe)|||/items/238157fd-0ae0-49de-85db-53fe0192adf5; Coats, A. (Andrew)|||/items/c707f8c3-36a0-4d45-9059-951c4b760d97; Seferovic, P. (Petar)|||/items/f6f00f3d-a8f0-47bc-9a93-b2a082f6707c | Publicado 2021 |
Herramientas de búsqueda:
Materias Relacionadas
alirocumab
acute coronary syndrome
PCSK9
Prognosis
cholesterol
AS A Coruña
CHUAC
Humans
Prevention
Acute heart failure
Alirocumab
Angiotensin receptor
Eligibility
Guidelines
Heart Failure
Heart failure
LCZ696
MI types
Mortality
PCSK9 protein
Registry
Sacubitril/valsartan
acute coronary syndromes
cerebrovascular disease
coronary artery bypass graft
death
global burden of disease
hospitalization
lipids
low-density lipoprotein cholesterol